| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 49,097 | 46,900 | 43,336 | 49,969 | | Cost of Revenue | 22,478 | 22,314 | 20,658 | 25,627 | | | Gross Profit | 26,619 | 24,586 | 22,678 | 24,342 | | | Operating Expenses | | Research Development | 14,789 | 13,811 | 14,891 | 15,471 | | Selling General and Administrative | 12,739 | 13,573 | 12,943 | 13,939 | | Non Recurring | 2,544 | (15) | (25) | 259 | | Others |
-
|
-
| 228 | 1,369 | | | | Total Operating Expenses |
-
|
-
| 28,037 | 31,038 | | | | Operating Income or Loss | (3,453) | (2,783) | (5,359) | (6,696) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (536) | 189 | (512) | (7,605) | | Earnings Before Interest And Taxes | (3,989) | (2,594) | (5,871) | (14,301) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (3,989) | (2,594) | (5,871) | (14,301) | | Income Tax Expense | 125 | 125 | (121) | 102 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,114) | (2,719) | (5,750) | (14,403) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,114) | (2,719) | (5,750) | (14,403) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,114) | ($2,719) | ($5,750) | ($14,403) |
|
0.31% Nasdaq 
0.05%
Income Statement
